Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

12.42 +0.59 (+4.99%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about NeoGenomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
3 Russell 2000 Stocks We Think Twice About
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
News headline image
3 Stocks Under $50 We Steer Clear Of
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how NeoGenomics (NASDAQ:NEO) and... 
Via StockStory
News headline image
3 Overrated Stocks That Concern Us
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro... 
Via StockStory
News headline image
Earnings Scheduled For October 28, 2025 ↗
 
Via Benzinga
News headline image
1 Cash-Burning Stock to Research Further and 2 We Brush Off
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
Via StockStory
Topics Retirement
News headline image
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
1 High-Flying Stock on Our Buy List and 2 We Find Risky
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
Via StockStory
News headline image
Earnings Scheduled For November 14, 2025 ↗
 
Via Benzinga
News headline image
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
3 Volatile Stocks We Keep Off Our Radar
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
News headline image
The Top 5 Analyst Questions From NeoGenomics’s Q3 Earnings Call
NeoGenomics’ third quarter results were met with a negative market reaction, as shares declined following the announcement. Management attributed the quarter’s performance to robust growth in clinical... 
Via StockStory
Topics Earnings
News headline image
NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings?
NeoGenomics trades at $9.78 per share and has stayed right on track with the overall market, gaining 24.7% over the last six months. At the same time, the S&P 500 has returned 21.3%. 
Via StockStory
Topics Stocks
News headline image
NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 11.9% year on year to $187.8 million. The company... 
Via StockStory
News headline image
NeoGenomics (NEO) Q3 2025 Earnings Call Transcript ↗
NeoGenomics (NEO) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Why NeoGenomics (NEO) Stock Is Trading Up Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 1.1% in the morning session after it reported third-quarter 2025 results where revenue beat Wall Street's expectations. 
Via StockStory
Topics World Trade
News headline image
NeoGenomics Inc (NASDAQ:NEO) Surpasses Q3 Revenue Estimates as Clinical Testing Drives Growth ↗
NeoGenomics Q3 2025 earnings beat revenue estimates with 11.9% growth. Clinical test volume surged 15%, driving a 5.4% pre-market stock rally. 
Via Chartmill
Topics Earnings
News headline image
NeoGenomics’s (NASDAQ:NEO) Q3 Sales Top Estimates, Stock Soars
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 11.9% year on year to $187.8 million. The company expects the full... 
Via StockStory
News headline image
NeoGenomics (NEO) Reports Earnings Tomorrow: What To Expect
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting results this Tuesday before market open. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks Walking a Fine Line
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
News headline image
3 Unprofitable Stocks with Open Questions
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
News headline image
Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
Washington D.C. – The Federal Reserve has sent clear signals of a continued dovish pivot, with Chair Jerome Powell indicating the likelihood of two additional quarter-point interest rate cuts before... 
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
News headline image
3 Russell 2000 Stocks We Approach with Caution
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics World Trade
News headline image
3 Cash-Burning Stocks We’re Skeptical Of
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to... 
Via StockStory
News headline image
NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026 ↗
Adhishthana.com analysis shows NeoGenomics has chosen the blue pill, consolidation likely to last until August 2026. 
Via Benzinga
News headline image
Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power
The U.S. financial markets are currently at a critical juncture, with the stability of the 10-year Treasury yield hovering steadfastly around the 4% mark. This apparent calm in long-term borrowing... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
1 Safe-and-Steady Stock Worth Your Attention and 2 We Ignore
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
Why NeoGenomics (NEO) Shares Are Falling Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 5.1% in the afternoon session after a key competitor, Exact Sciences, announced the launch of a new multi-cancer early... 
Via StockStory
Topics Intellectual Property Lawsuit
News headline image
Bond Yields Tumble as Investors Brace for Aggressive Fed Rate Cuts
U.S. Treasury yields have recently experienced a significant decline, with the benchmark 10-year Treasury note falling to its lowest levels since April 2025. This sharp dip in yields reflects a... 
Via MarketMinute
Topics Bonds Economy Supply Chain
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.